Ocplex

Human Coagulation Factor IX (recombinant), the active ingredient in Ocplex, is a blood coagulation factor presented as a sterile solution for intravenous use. It is used to manage bleeding episodes and to provide prophylaxis in patients with hemophilia B. GNH USA supplies Ocplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Ocplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Ocplex is a recombinant coagulation factor that replaces deficient clotting activity in the intrinsic pathway of the coagulation cascade.

- Hemophilia B: Provides factor IX activity to control and prevent bleeding episodes. - Acquired factor IX deficiency: Restores clotting function during surgical procedures or trauma. - Peri‑operative management: Used to maintain hemostasis in patients with known factor IX deficiency undergoing surgery.

Adverse reactions reported with recombinant factor IX products are generally mild to moderate and reflect immune or infusion‑related events.

Common Side Effects: - Headache  - Fever  - Nausea  - Mild infusion site erythema - Transient elevation of ALT levels - Fatigue 

Serious or Rare Side Effects: - Development of inhibitory antibodies against factor IX  - Anaphylactic or severe hypersensitivity reactions  - Thromboembolic events  - Severe hepatic dysfunction  - Disseminated intravascular coagulation  - Acute renal failure  -  

It  …  … … … … … ... 

---   etc…  ....  d…  …